Table 1.
Demographic variable | Donor controls | pa | ESRD, no DM at transplantation |
pb | |
---|---|---|---|---|---|
(n = 36) | no PTDM (n = 21) | PTDM (n = 11) | |||
Age, years | 43.5 [35, 53] | 0.35 | 46 [38, 53] | 46 [40, 62] | 0.56 |
Female | 24 (67) | 0.02 | 7 (33) | 3 (27) | 1.00 |
Race | 0.49 | 1.00 | |||
African-American | 4 (11) | 2 (10) | 3 (27) | ||
Caucasian | 31 (86) | 16 (76) | 8 (73) | ||
Other | 1 (3) | 3 (14) | 0 (0) | ||
BMI | 25 9 [22.2,28 6] | 0.41 | 27 9 [23.8,31 7] | 27 [25.1,33 5] | 1.00 |
Weight, lb | 165 [142, 187] | 0.11 | 184 [164, 220] | 180 [175, 220] | 0.92 |
Albumin, g/dl | 4.4 [4.3, 4.6] | 0.53 | 4.4 [4.2, 4.6] | 4.4 [4.2, 4.5] | 0.96 |
Fasting glucose, mg/dl | 86 [78, 92] | 0.17 | 86 [84, 93] | 92 [82, 97] | 0.64 |
Plasma creatinine, mg/dl | 0.8 [0.7, 0.9] | <0.01 | 7.7 [5.5, 9.8] | 7.6 [6.8, 9.6] | 1.00 |
Prior transplantation | 2 (10) | 3 (27) | 0.31 | ||
HCV antibody positive | 0 (0) | 0.47 | 1 (5) | 0 (0) | 1.00 |
CMV antibody positive | 15 (42) | 0.16 | 6 (29) | 7 (64) | 0.30 |
Type of transplant donor | 0.19 | ||||
Deceased | 5 (24) | 2 (18) | |||
Living - related | 11 (52) | 3 (27) | |||
Living - unrelated | 5 (24) | 6 (55) | |||
Type of renal replacement | 0.44 | ||||
Hemodialysis | 10 (48) | 7 (64) | |||
Peritoneal dialysis | 4 (19) | 0 (0) | |||
Preemptive | 7 (33) | 4 (36) | |||
Cause of CKD | 0.07 | ||||
Hypertension | 0 (0) | 2 (18) | |||
Glomerulonephritis | 10 (48) | 5 (45) | |||
Cystic/polycystic | 7 (33) | 0 (0) | |||
Lithium toxicity | 0 (0) | 1 (9) | |||
Obstruction | 0 (0) | 1 (9) | |||
Reflux nephropathy | 1 (5) | 0 (0) | |||
Systemic lupus erythematosus | 2 (10) | 0 (0) | |||
Unknown | 1 (5) | 2 (18) |
Two degrees offreedomtest for any differences between groups.
No PTDM versus PTDM.